Detalhe da pesquisa
1.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129464
2.
Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
Ann Surg Oncol
; 30(3): 1808-1819, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445500
3.
Machine-learning algorithm to predict multidisciplinary team treatment recommendations in the management of basal cell carcinoma.
Br J Cancer
; 126(4): 562-568, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471257
4.
Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Ann Surg Oncol
; 29(9): 5937-5945, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562521
5.
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Cancer
; 127(13): 2251-2261, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826754
6.
ASO Visual Abstract: Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
Ann Surg Oncol
; 30(3): 1822, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446952
7.
A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma.
Br J Cancer
; 115(2): 223-7, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27336602
8.
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.
Br J Cancer
; 115(10): 1193-1200, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27711083
9.
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
Lancet Oncol
; 15(6): 620-30, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24745696
10.
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
Eur J Cancer
; 196: 113455, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029480
11.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Eur J Cancer
; 205: 114103, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729054
12.
Small-Cell Carcinoma of the Prostate - Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece.
Oncol Ther
; 11(3): 291-301, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358792
13.
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial.
Clin Transl Radiat Oncol
; 41: 100597, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441544
14.
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
Eur J Cancer
; 194: 113344, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804771
15.
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
BJU Int
; 109(10): 1495-502, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933330
16.
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.
BJU Int
; 109(7): 994-1000, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854533
17.
Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease.
J Clin Oncol
; 40(34): 3940-3951, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849790
18.
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
J Immunother Cancer
; 10(8)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002183
19.
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
J Am Coll Surg
; 232(4): 424-431, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33316427
20.
Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Radiother Oncol
; 88(1): 121-6, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18499289